Second, deguelin down-regulated the proangiogenic characteristics in hepatocellular carcinoma cells by inhibiting the secretion of VEGF through the inhibition of HGF-c-Met signaling pathway (Figures 4–5). The gene discussed is MET; the disease is hepatocellular carcinoma.